MDGL
Madrigal Pharmaceuticals, Inc.
πΊπΈ NYSE/NASDAQ
π HIGH PRICE GROWTH
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 48.80%
Annual Growth
5 years average annual growth
π
3
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-Ξ² (THR-Ξ²) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Companyβs clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
π Performance
Price History*
+217.79%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$293.64
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in MDGL
3
π Total Capital Earnings
N/A
π Average investment frequency
44 weeks
π΅ Average investment amount
$502
β° Last time a customer invested in MDGL
70 days
MDGL investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
100%
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
100%
π Legal gender of investors
Female
100%
Male
Pearlers who invest in MDGL also invest in...
π Performance (5Yr p.a)
43.33%
π Share price
$84.83 USD
π HIGH PRICE GROWTH
π Performance (5Yr p.a)
31.35%
π Share price
$78.69 USD
π HIGH PRICE GROWTH
π Performance (5Yr p.a)
18.12%
π Share price
$36.10 USD
π HIGH PRICE GROWTH
Want more shares? Try these...
